| Literature DB >> 35117825 |
Lei Zhao1, Congzhe Tian1, Erbin Xiao1, Jinduo Du1, Jingwei Liang1, Xianghong Chen1, Weiwei Chi2.
Abstract
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) has the sixth-highest incidence rate of all malignant tumors. The occurrence and progress of HNSCC are induced by extensive molecular changes, resulting in a poor prognosis. The present study aims to explore how altered microRNAs (miRNAs) and their co-expression networks of miRNAs-target mRNAs in HNSCC and to provide references for diagnosis and therapy research.Entities:
Keywords: Head and neck squamous cell carcinoma (HNSCC); bioinformatics; head and neck tumor; microRNA (miRNA)
Year: 2020 PMID: 35117825 PMCID: PMC8797951 DOI: 10.21037/tcr-20-1145
Source DB: PubMed Journal: Transl Cancer Res ISSN: 2218-676X Impact factor: 1.241
Figure 1Flow-chart for articles evaluation and screening. HNSCC, head and neck squamous cell carcinoma.
Figure S1Co-expression network between Grade A miRNAs and target mRNAs. The red and green squares are up-regulated and down-regulated miRNAs in HNSCC, respectively. The dots stand for target mRNAs, and the size of dots represents the number of edges pointing to it. The thickness of the edges represents the target score of miRNA to target mRNA. The yellow dots are the 13 mRNAs included in signaling pathways related to epithelial-mesenchymal transformation. EBV-miR-BART1 is not included in miRNA target prediction databases, and its target mRNA was reported in the earlier study. HNSCC, head and neck squamous cell carcinoma.
Figure S2Co-expression network between Grade B miRNAs and target mRNAs. Nodes and edges have the same meaning as Grade A network. Besides, the yellow dots are the eight mRNAs included in the HIF-1 signaling pathway. The red circles indicate the upstream miRNAs of the eight mRNAs.
Figure S3Co-expression network between Grade C miRNAs and target mRNAs. Nodes and edges have the same meaning as Grade A network.
Figure 2GO and KEGG pathway analyses of target mRNAs from Grade A. A total of 816 mRNAs were included in the analyses. The brown bars show the proportion of mRNAs contained in each GO module or KEGG pathway. The light pink bars represent the proportion of mRNAs contained in each GO term or KEGG pathway. GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes.
KEGG pathway analysis of Grade A
| KEGG pathway | Count | P value | Genes | Fold enrichment | FDR |
|---|---|---|---|---|---|
| hsa04151:PI3K-Akt signaling pathway | 32 | 2.57×10–4 |
| 2.000164 | 0.329683 |
| hsa04010:MAPK signaling pathway | 26 | 2.47×10–4 |
| 2.216090 | 0.316678 |
| hsa04310:Wnt signaling pathway | 21 | 4.57×10–6 |
| 3.281518 | 0.005860 |
* means the mRNA included in two or three pathways. KEGG, Kyoto Encyclopedia of Genes and Genomes; FDR, false discovery rate.
Figure 3Sub-network of selected miRNAs and target mRNAs. The red and green squares are up-regulated and down-regulated miRNAs in HNSCC, respectively. The yellow dots are the 13 mRNAs included in signaling pathways related to epithelial-mesenchymal transformation. The size of the dots represents the number of edges pointing to it. The thickness of edges represents the target score of miRNA to target mRNA. All nodes and edges derived from the co-expression network of Grade A. HNSCC, head and neck squamous cell carcinoma.
Figure 4Expression levels and survival analyses of selected target mRNAs from Grade B. (A) Expression levels and (B) overall survival analyses of target mRNAs were completed by Gene Expression Profiling Interactive Analysis (GEPIA) based on The Cancer Genome Atlas and Genotype-Tissue Expression databases. The y-axis is mRNA expression levels in terms of log2 (TPM+1) (C: cancerous samples, 519; N: normal samples, 44 from GEPIA; P≤0.01). TPM, transcripts per million.
Figure 5Sub-network and expression levels of selected miRNAs and target mRNAs from Grade C. (A) Sub-network derived from Grade C co-expression network; (B) expression levels of selected mRNAs based on Gene Expression Profiling Interactive Analysis (GEPIA) (C: cancerous samples; N: normal samples).